FDA Rejects Latest Weight Loss Drug
Arena Pharmaceuticals of San Diego recently received some bad news; the US Food and Drug Administration (FDA) has rejected the company’s application for Lorcaserin, the company’s new weight-loss drug. Arena hoped that Lorcaserin would be the newest addition to the booming US weight-loss drug market; a full third of American adults are considered to be [...]
Stomach Hormone Could Explain Why Some People Compulsively Eat
A new study from researchers at the University of Gothenburg in Sweden has found that a stomach hormone called ghrelin controls whether rats seek out food or lose interest in food. Ghrelin is one of many chemicals that tell the brain when to trigger hunger or fullness. Previous research has shown that ghrelin also acts [...]
Rebooting Metabolism
Many people are predisposed to develop obesity or diabetes, but there is also an element of individual choice that plays a significant role in the development of the diseases. The biological background of the choices that individuals make is hard to understand, specifically when it comes to two culprits often striking a nutritional imbalance: proteins [...]
FDA Cracks Down on Obesity Drug
Citing safety concerns, the U.S. Food and Drug Administration (FDA has placed restrictions on the use of GlaxoSmithKline’s Avandia (generic name “rosiglitazone”), a prescription drug that is marketed for treating type 2 diabetes. GSK’s other drugs that contain rosiglitazone, Avandamet (with metformin) and Avandaryl (with glimepiride), have also been restricted. The FDA has proposed requiring [...]
